Skip to content
Home » News » New York State » Hochul signs two bills addressing rising costs of prescriptions: What will they accomplish?

Hochul signs two bills addressing rising costs of prescriptions: What will they accomplish?

  • / Updated:
  • Staff Report 

Governor Kathy Hochul has signed two significant pieces of legislation designed to address the rising costs of prescription drugs and enhance the safety and accessibility of pharmaceutical drug administration.

The first, Legislation S.599-A/A.1707, introduces stricter transparency measures for prescription drug pricing, requiring manufacturers to report any proposed wholesale price increases to the New York State Department of Financial Services. The second, Legislation A.6779-A/S.6337-A, broadens the scope of medications that pharmacists can administer, particularly for mental health and substance use disorders, and mandates communication between pharmacists and prescribing physicians regarding medication administration.


Governor Hochul emphasized that these legislative measures aim to alleviate the financial burden of prescription drugs for New Yorkers and increase the safety of medication administration. The new laws represent a significant step towards health care reform, especially in addressing the high costs of prescription drugs, which has been a growing concern for many residents.

Assemblymember John T. McDonald III, RPh, highlighted the importance of the new legislation in reducing barriers to medication access, especially in health care deserts across urban and rural areas. By allowing patients to receive long-acting injectable medications for mental health and substance use disorders at local pharmacies, the laws aim to ensure that New Yorkers have greater access to necessary medications and care. This initiative is seen as an essential move in meeting patients’ needs and improving overall health care services in the state.